Pricing Log in Create free account

BRIACELL THERAP (BCTX) vs CervoMed Inc. (CRVO)

BRIACELL THERAP and CervoMed Inc. are both Biotechnology companies. BRIACELL THERAP and CervoMed Inc. are of similar size ($34.0M and $32.8M). CervoMed Inc. has negative trailing earnings, so its P/E is not meaningful; BRIACELL THERAP trades at 1.5×. Across the 10 metrics below, CervoMed Inc. leads on 7 and BRIACELL THERAP on 3.

Valuation

Metric BCTX CRVO Biotechnology median
P/E 1.53 n/m 8.50
P/S n/m 5.73 9.71
P/B 1.06 1.00 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 2.74 9.21
Earnings yield 65.24% (143.75%) (33.15%)
Free cash flow yield (126.67%) (123.82%) (25.50%)

Profitability

Metric BCTX CRVO Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (173.55%) (107.62%) (56.36%)
Return on assets (139.20%) (94.73%) (48.04%)
Return on invested capital (3,311.00%) 0.00% 0.00%

Growth

Metric BCTX CRVO Biotechnology median
Revenue growth (TTM) — (58.86%) 6.02%
EPS growth (last fiscal year) (43.04%) (47.52%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCTX CRVO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.07 8.57 4.72
Net debt to EBITDA 0.66 0.74 0.96

Dividend

Metric BCTX CRVO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BCTX CRVO Biotechnology median
Market cap 32.76m 34.02m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack